Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
Research has shown that having obesity or type 2 diabetes can worsen psoriasis symptoms, which suggests that treatments aimed at controlling blood sugar and body weight might benefit people with psoriatic arthritis
ReadyRx GLP-1 is one of the platforms operating in this space
Looking more closely at people living with diabetes, a recent meta analysis of 11 randomized controlled trials found that GLP-1s significantly reduced both cardiovascular and kidney events (such as kidney failure)
It not only provides almost immediate balancing of hormones, including GLP-1, [but] it also addresses long-term metabolic health by activating the same enzyme created by endurance exercise. The bottom line
[3] [4] Despite the absence of confirmed human cases directly attributable to GLP-1 therapy, the FDA requires this warning as a precautionary measure for many GLP-1 medications
